The National Partnership to Improve Dementia Care in Nursing Homes, a public-private coalition under the guidance of CMS, has recently released findings showing a nearly 20% three-year decline in antipsychotic use. Leaders at the American Health Care Association (AHCA) say they plan to keep the momentum going to further curb antipsychotic use in nursing homes. According to CMS data, 19.2% of nursing home residents were receiving an antipsychotic medication in the third quarter of 2014 – down from 23.9% in the fourth quarter of 2011. The AHCA’s goal is to further reduce off-label use by another 10% this year and 5% more by the end of 2016. The decline in antipsychotic use is evidence of the success of the Quality Initiative the AHCA embarked on three years ago. The coalition was originally “developed to improve dementia care through the use of individualized, comprehensive care approaches” and seeks to “promote a systematic process to evaluate each person and identify approaches that are most likely benefit that individual.”
Click here to read more.